PA5-19242
antibody from Invitrogen Antibodies
Targeting: TGFBI
BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-19242 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- TGFBI Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- This antibody is predicted to react with canine, mouse and rat based on sequence homology.
- Reactivity
- Human
- Host
- Goat
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 0.5 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.
Liu B, Yang H, Taher L, Denz A, Grützmann R, Pilarsky C, Weber GF
Translational oncology 2018 Jun;11(3):700-714
Translational oncology 2018 Jun;11(3):700-714
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot staining of Human Kidney lysate using Product # PA5-19242 at a concentration of 0.3 µg/mL, the primary antibody incubation was 1 hour and the detection method was chemiluminescence.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of TGFBI in paraffin embedded human kidney using a TGFBI polyclonal antibody (Product #PA5-19242) at a concentration of 3.8 µg/mL. Steamed antigen retrieval was performed with pH 6 buffered citrate. Samples were then stained with alkaline phosphatase.